$EVER

EverQuote, Inc.

No enriched coverage for $EVER in the last 7 days.

$957K
Shields John L.
86%
See all $EVER insider activity →
Low

Mendal Jayme sold $509K of EVER

Mendal Jayme (CEO and President) sold 20,981 shares of EverQuote, Inc. (EVER) at $24.27 ($0.51M total) on 2026-09-15 under a Rule 10b5-1 trading plan.

EverQuote (EVER) Shares Skyrocket, What You Need To Know

EverQuote (EVER) shares rose 5.7% after JPMorgan initiated coverage with an Overweight rating and $29 price target. The company reported Q2 revenue of $195.1M, up 25%, and adjusted EBITDA of $30.1M, up 37%. Management guided Q3 revenue to $198-208M and adjusted EBITDA to $28-31M.

EVER sentiment & insider activity

Recent EVER coverage spans earnings, insider activity and market movers.

In the last 30 days, EVER insiders filed 7 SEC Form 4 transactions — no purchases and 7 sales ($957K). The most active reporter was Shields John L. with 2 filings. 86% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving EVER

AlphAI scores every news story that mentions EVER with an AI model for sentiment and relevance, and aggregates insider trades from EverQuote, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $EVER

Score
$EVERMed

EverQuote at Oppenheimer conference: growth, ai and cash flow

EverQuote (EVER) told investors at the Oppenheimer conference that it has generated nearly $200 million in free cash flow over the past two years. The company reported 25% YoY Q2 revenue growth and 37% YoY EBITDA growth, and reiterated a path to $1 billion revenue in 15 to 27 months from its Nov 2025 target, driven by organic growth and AI-enabled Smart Campaigns.

$EVERMedAI 8/10

Why EverQuote (EVER) Stock Is Up Today

EverQuote (NASDAQ:EVER) shares rose about 9% after the insurance marketplace reported Q2 results and guidance. Revenue increased 25% to $195.1 million, adjusted EBITDA rose 37% to a record $30.1 million, and management projected Q3 revenue of $198–$208 million and adjusted EBITDA of $28–$31 million. The stock closed at $25.71, up 7.9%.

$EVERMedAI 8/10

Why EverQuote (EVER) Stock Is Up Today

EverQuote (NASDAQ: EVER) shares rose about 9.4% intraday after the insurance marketplace reported Q2 revenue up 25% to $195.1 million and record adjusted EBITDA up 37% to $30.1 million. Auto revenue rose ~23% and home/renters ~35%. Q3 guidance calls for revenue $198–$208 million and adjusted EBITDA $28–$31 million.

$EVERMed

EverQuote, Inc. Q2 2026 Earnings Call Summary

EverQuote reported Q2 2026 results driven by record carrier and agent revenue, 35% YoY growth in home insurance, and Smart Campaigns AI bidding revenue up more than 100% YoY. Management reaffirmed $1B annual revenue within 15 to 27 months and guided Q3 operating expense increases of about $1.0M to $1.25M. It repurchased 578,000 shares for about $9M and said it has $192M cash with no debt.

$EVERMed

What To Expect From EverQuote’s (EVER) Q2 Earnings

EverQuote (NASDAQ:EVER) will report Q2 results Monday after market close. The company beat last quarter’s revenue expectations with $190.9 million revenue, up 14.5% year over year. For Q2, analysts expect 21.5% YoY revenue growth. The article cites an average analyst price target of $26.20 versus $25.22 and notes peers’ mixed results.

Related tickers